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ABSTRACT
Purpose To determine the impact of a physician-
directed, multifaceted health information tech-
nology (HIT) system on diabetes outcomes.
Methods A pre/post-interventional study.
Setting and participants The setting was Provi-
dence Primary Care Research Network in Oregon,
with approximately 71 physicians caring for 117 369
patients in 13 clinic locations. The study covered
Network patients with diabetes age 18 years and
older.
Intervention The study intervention included im-
plementation of the CareManagerTM HIT system
which augments an electronic medical record (EMR)
by automating physician driven quality improvement
interventions, including point-of-care decision sup-
port and care reminders, diabetes registry with care
prompts, performance feedback with benchmark-
ing and access to published evidence and patient
educational materials.
Measures The primary clinical measures included
the change in mean value for low density lipopro-
tein (LDL) target <100 mg/dL or 2.6 mmol/l, blood
pressure (BP) target <130/80 mmHg and glycated
haemoglobin (HbA1c) target <7%, and the pro-
portion of patients meeting guideline-recommen-
ded targets for those measures. All measures were
analysed using closed and open cohort ap-
proaches.
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Introduction
Diabetes is a common, costly, serious and growing
health problem.1 It is expected that more than one in
three Americans born in 2000 will develop diabetes
during their lifetimes.2 Although there is no cure,
diabetes can be controlled through quality medical care
and self-management. Despite annually updated Amer-
ican Diabetes Association (ADA) guidelines and eﬀective
pharmacotherapy, data continue to demonstrate poor
control of the risk factors for vascular disease.3–6
Diabetes management is predominantly provided
in the outpatient setting.7,8 The episodic nature of
ambulatory medicine has been invoked as a contributor
to shortfalls in management of chronic conditions.9
In the episodic model, practitioners attend to the care
of patients typically in the setting of appointments
scheduled by the patient. Thismodel is strongly driven
by patients’ perception of the acuity of their medical
conditions.Theseperceptions are inﬂuencedbypatients’
understanding of their disease processes and symp-
toms, insights that are often lacking in chronic ill-
ness.10 Practitioners may also be distracted from the
management of chronic illness by patients’ unrelated
acute complaints11 and often lack the resources required
to provide optimal system-based approaches.12
Numerous interventions have been proposed to
overcome shortfalls in quality of diabetes care. ‘Phys-
ician-directed’ quality improvement interventions in-
clude provider education, point-of-care reminders,
audit and feedback and registries. Two recent system-
atic reviews evaluated interventions to improve dia-
betes management.13,14 Both reviews found that
physician-directed interventions resulted in improved
processes, but not outcomes of diabetes care. This pre/
post-interventional studywas conducted to determine
the eﬀectiveness of automating multiple physician-
directed diabetes interventions, using a single health
information technology (HIT) system.
Methods
Study site and participants
The study was conducted within the Providence
Primary Care Research Network. The Network is part
of Providence Health and Services (PH&S), a not-for-
proﬁt integrated delivery system.AllNetwork primary
care, community-based, non-academic clinics were
included in the study, with the exception of three clinics
involved in another diabetes improvement project
(Figure 1). Participating clinics comprised approx-
imately 71 internal and family medicine physicians
caring for 117 369 patients in 13 clinic locations. All
clinics utilise the GE Centricity EMR to facilitate and
document patient care activities.
Participating patients within eligible practices were
identiﬁed by a problem list entry of diabetes (ICD-9
codes 250.xx) and age3 18 years. Participants were
excluded if they had no evidence of chart activity (i.e.
documentation of an oﬃce visit, prescription reﬁll or
phone contact) within three years.
Intervention
The HIT system (CareManagerTM) was designed to
enable physicians to co-ordinate eﬀective population-
based care with minimal ongoing practice expense.
CareManagerTM’s diabetes module includes a suite of
integrated point-of-care and web-based tools:
1 Point-of-care An EMR-based decision support tool
(‘diabetes dashboard’) alerts physicians to diabetes
care opportunities at the time of a visit (Figure 2a).
2 Web-based population system This includes the
following features:
. Tracking system – automatic daily extracts of
EMR data with reformatting to support popu-
lation management. Users view their list of
Results A total of 6072 patients were identiﬁed at
baseline, 70% of whom were continuously enrolled
during the 24-month study. Signiﬁcant improve-
ments were observed in all diabetes related out-
comes except mean HbA1c. LDL goal attainment
improved from 32% to 56% (P=0.002), while mean
LDL decreased by 13 mg/dL (0.33 mmol/l, P=0.002).
BP goal attainment increased signiﬁcantly from
30% to 52%, with signiﬁcant decreases in both
mean systolic and diastolic BP. The proportion of
patients with an HbA1c below 7%was higher at the
end of the study (P=0.008). Mean patient satisfac-
tion remained high, with no signiﬁcant diﬀerence
between baseline and follow-up. Total Relative
Value Units per patient per year signiﬁcantly
increased as a result of an increase in the number
of visits in year one and the coding complexity
throughout.
Conclusion Implementationof a physician-directed,
multifaceted HIT system in primary care was asso-
ciated with signiﬁcantly improved diabetes process
and outcome measures.
Keywords: diabetes, health information tech-
nology, primary care
The impact of a physician-directed HIT system on diabetes outcomes in primary care 167
diabetes patients with colour-coded highlights
for care opportunities relative to ADA guidelines
(Figure 2b).
. Performance feedback – automated monthly
trends in physician and clinic performance on
process and outcome diabetes measures.
. Benchmarking – performance reports include
evidence-based peer benchmarking.15
. Physician education – access to relevant diabetes
guidelines and literature.
. Patient education – access to diabetes patient
self-management materials.
Implementation strategy
All practitioners and staﬀ were encouraged to attend a
90-minute training session for (1) inspiration, (2) system
instruction and (3) best practice workﬂows. For in-
spiration, each session started with a video of physicians
and staﬀ from pilot sites discussing their experience
with the system during a one-year pilot. System
instruction involved a clinician (JSH, JS or BHL)
providing guided tours of system navigation and
functionality. Best practice workﬂows from the pilot
were shared in written and verbal form. Following
training, diabetes measures were reviewed quarterly
during clinic meetings. No additional staﬀ, resources
or instructions were provided. Physicians and staﬀ
had the autonomy to implement the system to the
extent and in the format chosen.
Measurements
Clinical
Theprimary clinical outcomemeasures included change
in mean LDL-cholesterol (<100 mg/dL or 2.6 mmol/1),
blood pressure (<130/80 mmHg) and glycated hae-
moglobin (HbA1c – <7%), and the proportion of
Figure 1 Diabetes study population ﬂowchart
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Figure 2b Diabetes registry treatment tab
Figure 2a Diabetes dashboard
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patients meeting guideline recommended targets.16
Diabetes related process measures included the pro-
portion of subjects receiving annual LDL, blood press-
ure and HbA1c testing. Additional measures included
documentation of anti-platelet therapy and pneumo-
coccal vaccination, as well as diabetic foot and retinal
exams within the previous 12 months.
Satisfaction
Patient satisfaction with diabetes related care was
assessed using the ADA-NCQA Provider Recognition
Program (PRP)Modiﬁed Patient Satisfaction Survey.13,17
The survey was mailed to a subset of 3000 patients
selected randomly at baseline and study end. The
ADA-NCQA PRP satisfaction survey rates patient
satisfaction on nine components of diabetes treat-
ment.Overall satisfactionwas evaluated by calculating
mean satisfaction per subject across all nine com-
ponents. Additionally, the two highest responses were
combined to evaluate the percentage of patients that
were mostly satisﬁed with their care.
Oﬃce visits
Financial measures were assessed from the physician
organisation perspective. Information on visit frequency
and complexity was extracted from the Network’s
practice management system. Change in the com-
plexity of visits was assessed using a relative value
unit (RVU). An estimated net revenue impact was
calculated as a product of a total RVU, internal con-
version ($80) and collection factors (60%).
Statistical analysis
Descriptive statistics, proportions, means and stan-
darddeviations (SD)wereused toexaminedemographic
characteristics of patients and providers. Continuous
data were described bymean (SD) and comparedusing
paired and unpaired t-tests. Categorical data were
described by percentages and compared byChi-square
tests with continuity correction. The McNemar test for
paired proportions was used to evaluate the diﬀerence
between time periods among continuously enrolled
patients. The signiﬁcance level was set at 0.05. The
Bonferroni method was used to correct concerns caused
by multiple analysis of the same data.18,19
Study outcomes were measured at baseline and 24
months. The primary study analysis was conducted
for patients with diabetes active within the practice for
the entire 24-month study period (closed cohort). A
second analysis was conducted comparing all patients
active at baseline with all patients active at study end
(open cohort). This latter analysis does not allow every
patient the beneﬁt of 24 months’ exposure to the
intervention, but is a method of quality performance
assessment that is widely utilised and reported.
Changes in mean number of oﬃce visits per patient
per year, mean total RVUs per visit and mean net
revenue impact were evaluated by unpaired t-test. In-
crease in the complexity of reimbursement coding was
measured by chi-square testing for proportions. All
analyses were completed using SAS version 9.1 (SAS
Institute, Cary NC).
Results
A total of 6072 eligible patients were identiﬁed at
baseline. Table 1 displays the characteristics of par-
ticipating physicians and their diabetes panels. Of the
patientswithdiabetes identiﬁedatbaseline, 4265 (70.2%)
were continuously enrolled during the 24-month study
(Figure 1). An additional 3607 new patients with
diabetes received care from the Network and 2223
left theNetwork at some time during the study period.
Clinical
Outcome measures
Two years after implementation, signiﬁcant improve-
ments were observed in all diabetes related outcomes
with the exception of mean HbA1c (Table 2). In the
primary analysis of continuously enrolled patients,
LDL goal attainment improved signiﬁcantly from 32%
at baseline to 56% at study end (P=0.002), while the
mean LDL decreased by 13 (0.33mmol/l, P=0.002).
Similarly, blood pressure goal attainment increased
signiﬁcantly from 30% to 52% with statistically sig-
niﬁcant decreases in mean systolic and diastolic press-
ures (5 mmHg and 3 mmHg respectively). Although
mean HbA1c was not changed, the proportion of
patients below HbA1c target was signiﬁcantly higher
at study end (P=0.008). No diﬀerences in outcome
were identiﬁed when the data for the open cohort was
analysed.
Process measures
In the continuously enrolled population, there were
signiﬁcant improvements in most diabetes related
process measures (Table 2). There was statistically
signiﬁcant improvement in the proportion of patients
having LDL and HbA1c laboratory tests within the
previous 12months (16% and 7% respectively). There
were also signiﬁcant increases in the proportion of
patients with a documented prescription for lipid
lowering, ACEI/ARB, oral hypoglycaemic and anti-
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platelet therapies. In addition, there were signiﬁcant
increases in documentation of retinal (39% to 59%)
and diabetes foot (26% to 79%) examinations.
Satisfaction
The response rate for the satisfaction survey was 21.4%
(641/3000) at baseline and 26.2% (785/3000) at study
end. No signiﬁcant diﬀerence in satisfaction was
identiﬁed in individual survey items (Table 3). Overall
satisfaction remained high with no statistical change
from baseline (mean=5.2, SD=1.1, P=0.67). Addition-
ally, no association was found between patient satis-
faction and clinical outcome measures.
Oﬃce visits
As seen in Table 4, themean number of oﬃce visits per
patient per year in the open cohort increased signiﬁ-
cantly following implementation of the intervention
(P<0.0001). In the second year of the intervention, the
number of visits returned to slightly below baseline
(P<0.0001). Complexity of reimbursement coding
continued to increase over the two years of the study.
As a result, total RVUs per visit signiﬁcantly increased
in the ﬁrst and second years following implemen-
tation. This translated into a $4 increase in net revenue
impact per visit from baseline to the study end. The
combined positive eﬀect on annual revenue resulting
from changes in oﬃce visit frequency and coding
Table 1 Physician and patient characteristics at baseline
Physician (PCP) characteristics
Total number of physicians, n 71
Total number of full-time equivalents (FTEs) 61
Physicians per clinic – mean (SD) 5 (2)
Part-time physicians, % 52
Specialty type, %
Family medicine 52
Internal medicine 48
Gender, female (%) 58
Panel size per physician FTE – mean (SD) 1971 (862)
Patients with diabetes per physician FTE – mean (SD) 91 (62)
Patients with diabetes per clinic – mean (SD) 379 (282)
Patient characteristics
Total number of patients with diabetes, n 6072
Gender, female (%) 56
Age, years – mean (SD) 62 (15)
Smoking, % 11
Insurance, %
Self-pay/no insurance 3
Commercial 46
Medicare 46
Medicaid or other 5
BMI – mean (SD) 34 (11)
Hypertension, % 60
Serum creatinine – mean (range) 1.1 (0.3–14)
Creatinine clearance – mean (SD) 98 (59)
Microvascular complications
Documented retinopathy, % 3
Documented neuropathy, % 10
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Table 2 Diabetes outcomes and process measures in continuously enrolled patients
(n=4265)
Baseline Study end P-value*
Oﬃce visit within the past 12 months (%) 96 95 0.99
LDL cholesterol
LDL test within past 12 months (%) 70 86 0.002
Mean LDL, mg/dL (SD) 106 (33) 93 (31) 0.002
LDL goal attainment, <100 mg/dL (%) 32 56 0.002
Any lipid lowering medication (%) 48 70 0.002
Blood pressure (BP)
BP measures within past 12 months (%) 95 96 0.99
Mean SBP, mmHg (SD) 133 (18) 128 (16) 0.002
Mean DBP, mmHg (SD) 75 (11) 72 (11) 0.002
BP goal attainment, <130/80 mmHg (%) 30 52 0.002
ACEI or ARB (%) 54 69 0.002
Glycaemia
HbA1c test within past 12 months (%) 83 90 0.002
Mean HbA1c, % (SD) 7.11 (1.4) 7.13 (1.4) 0.23
HbA1c goal attainment, <7% (%) 47 50 0.008
Diabetes therapy (%)
Insulin 20 25 0.18
Oral hypoglycaemic medications 56 68 0.002
Anti-platelets, age>40 (%) 54 88 0.002
Other process measures (%)
Retinal eye exam 39 59 0.002
Diabetes foot exam 26 79 0.002
Pneumococcal vaccination 54 90 0.002
*P-value adjusted for multiple comparisons
Table 3 Patient satisfaction comparing baseline to study end
During the past 12 months Baseline
% (N/D)
Study end
% (N/D)
P-
value
Satisfaction with overall care of diabetes 81 (513/635) 80 (620/777) 0.64
Satisfaction with the way questions were answered 82 (520/635) 80 (617/772) 0.35
Satisfaction with reaching someone in an emergency 80 (461/579) 77 (537/696) 0.29
Satisfaction with review of test results 81 (517/638) 79 (612/780) 0.23
Satisfaction with quality of diabetes information 78 (488/629) 75 (574/765) 0.27
Satisfaction with respect shown to you 88 (566/641) 87 (686/785) 0.60
Satisfaction with the way the staﬀ co-ordinate 85 (541/634) 83 (629/762) 0.16
Would you recommend us to your family and friends 84 (531/631) 84 (643/766) 0.92
Satisfaction with the ease of scheduling 85 (542/635) 87 (677/781) 0.47
Note: Percentages represent patient responses mostly satisﬁed (5 and 6 on scale from 0 to 6)
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complexity was $546 864 in year one and $427 776 in
year two.
Discussion
The results of this study demonstrate favourable
changes in diabetes process and outcome measures
following implementation of a robust automated HIT
system. The change in primary outcome, LDL goal
attainment, implies that a patient with diabetes may
be as much as 75% more likely to achieve optimal
cholesterol management in a practice using this HIT
intervention. Considering the simultaneous improve-
ments in multiple other processes and intermediate
outcomes, the clinical impact of this intervention
appears substantial.
Many organisations adopt EMR systems anticipat-
ing that the technology will improve quality. Our own
experience6 correspondswithemergingevidencedemon-
strating that EMRs, as currently implemented, do not
result in better quality ambulatory care.20 Addition-
ally, prior studies of population-based21,22 or point-
of-care23,24 physician-directed diabetes interventions
have failed to demonstrate meaningful improvement
in clinical outcomemeasures. The results of this study
suggest a synergistic eﬀect when multiple physician-
directed strategies are implemented within an HIT
system augmenting an EMR.
Although HbA1c goal attainment signiﬁcantly
improved, this intervention had no eﬀect on mean
HbA1c. Several potential explanations exist for the
negligible impact, including the heightened role of
patient self-management and the complexity of medi-
cation management. Valuable improvements in HbA1c
may require the addition of a structured behavioural
intervention.
This study also demonstrated no impact on patient
satisfaction. The lack of correlation between improve-
ments in multiple aspects of diabetes care and satis-
faction is consistent with other ﬁndings that patients’
perception of care is based on factors other than
eﬀectiveness.25 However, these results may help to
dispel the notion that introducing more proactive
disease management in primary care risks jeopardis-
ing the physician–patient relationship. Further, the
increasing prevalence of public transparency of quality
measures may yield a more educated patient popu-
lationwhowould place higher value on improvements
in clinical care and patient outreach.
In contrast to external, non-clinic based (‘carve
out’) disease management programs, several elements
of this intervention are attractive to physicians.26 This
physician-directed intervention relies on data accessed
directly from patient charts, as opposed to adminis-
trative claims data. Because the program continuously
extracts the requisite information from existing EMR
data, the improvement was accomplished without
added staﬃng requirements. Importantly, it also in-
cludes the clinician’s entire diabetic panel, regardless
of insurance coverage.
Table 4 Oﬃce visits and coding complexity, comparing baseline to one and two years post-
implementation
Baseline Post-implementation
1 year 2 years
n 6072 6668 7456
Total visits for patients with diabetes 24 445 29 899 28 073
No. visits per patient with diabetes 4.0 4.5* 3.8
Coding level – %
99212 2.1 1.9 2.2
99213 50.7 43.6 37.9
99214 47.2 54.5* 59.8*
Total RVU** – mean (SD) 1.76 (0.4) 1.82* (0.4) 1.85* (0.4)
Total RVU** 43 023 54 416 51 935
Total revenue $2 065 104 $2 611 968 $2 492 880
* Statistically signiﬁcant improvement from baseline, **P<0.001
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In the absence of capitation, risk, or pay-for-per-
formance, provider organisations may question the
business justiﬁcation for the costs associated with
internal quality improvement programs. This study
provides valuable insights into enhanced fee-for-service
revenue from increased frequency and complexity of
oﬃce visits. Further, the automated capture of clinical
data from an EMR eliminates the costs of manual data
entry traditionally associated with stand-alone regis-
tries. Revenue from ancillary services, including lab-
oratory testing, and professional fees from dilated
retinal exams was not included in this analysis.
This study has several strengths, including (1) a
setting of community-based physicians practicing in
multiple clinic locations, (2) the 24-month study dur-
ation, (3) a large diabetes population with a diverse
payer mix, (4) a comprehensive inventory of clinical
process and outcome measures and (5) inclusion of
patient satisfaction and ﬁnancial outcomes.
There are also several notable study limitations.
Although the pre/post-study design was considered
more ethical, this methodology limits the ability to
draw ﬁrm conclusions. A randomised, controlled study
would be needed to draw conclusions regarding the
isolated impact of the intervention. A concern with
this study design is the potential for state-of-health bias
(i.e. diﬀerence between patient characteristics at base-
line and follow-up).27 We attempted to minimise this
issue by evaluating continuously enrolled subjects for
the primary analysis. A potential confounding factor
in this study was the simultaneous existence of a
modest tiered performance incentive for clinicians
(up to $600). The relevant performance measure was
limited to blood pressure control. Interestingly, goal
attainment for blood pressure and LDLwere similar in
this study despite the lack of monetary incentive for
the latter.
Conclusion
Implementation of anHIT system in primary care was
associated with signiﬁcantly improved diabetes process
and outcome measures. This improvement occurred
in a setting with 13 clinics, 71 physicians and 7500
patients with diabetes. Because the program continu-
ously extracts the requisite information from existing
EMR data, the improvement was accomplished with-
out added staﬀ. This internal disease management
intervention had negligible eﬀect on patient satisfac-
tion, but did enhance revenue for the physician
organisation.
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